The Manufacturers Life Insurance Company Acquires New Holdings in Ingevity Corporation $NGVT

Posted by Geri Gentry on Sep 5th, 2026

The Manufacturers Life Insurance Company bought a new stake in shares of Ingevity Corporation (NYSE:NGVT – Free Report) in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm bought 17,481 shares of the company’s stock, valued at approximately $1,305,000. The Manufacturers Life Insurance Company owned approximately 0.05% of Ingevity at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Global Retirement Partners LLC acquired a new stake in shares of Ingevity in the fourth quarter valued at approximately $27,000. Meeder Asset Management Inc. purchased a new stake in Ingevity in the 4th quarter valued at approximately $33,000. Geneos Wealth Management Inc. grew its holdings in Ingevity by 85.8% during the 2nd quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock valued at $36,000 after buying an additional 387 shares during the last quarter. Frazier Financial Advisors LLC acquired a new stake in Ingevity during the 2nd quarter valued at $37,000. Finally, Headlands Technologies LLC purchased a new position in Ingevity during the second quarter worth $46,000. Institutional investors and hedge funds own 91.59% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on NGVT. Weiss Ratings raised Ingevity from a “sell (d-)” rating to a “hold (c-)” rating in a report on Friday, July 31st. Wall Street Zen cut Ingevity from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 1st. Two research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $80.00.

View Our Latest Analysis on NGVT

Ingevity Price Performance

Ingevity stock opened at $70.56 on Friday. The company has a quick ratio of 1.15, a current ratio of 1.61 and a debt-to-equity ratio of 22.52. The firm has a market capitalization of $2.43 billion, a P/E ratio of 48.00 and a beta of 1.17. The firm has a fifty day moving average of $73.06 and a 200-day moving average of $71.62. Ingevity Corporation has a 52-week low of $45.85 and a 52-week high of $79.29.

Ingevity (NYSE:NGVT – Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The company reported $1.74 earnings per share for the quarter, topping analysts’ consensus estimates of $1.33 by $0.41. Ingevity had a net margin of 4.65% and a return on equity of 284.70%. The firm had revenue of $314.10 million during the quarter, compared to analysts’ expectations of $312.20 million. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. As a group, analysts predict that Ingevity Corporation will post 5.4 EPS for the current year.

Insider Transactions at Ingevity

In other news, CEO David Li sold 5,000 shares of the company’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $75.83, for a total value of $379,150.00. Following the completion of the sale, the chief executive officer owned 120,636 shares of the company’s stock, valued at $9,147,827.88. This represents a 3.98% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Ryan Fisher sold 2,709 shares of the stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $73.72, for a total value of $199,707.48. Following the completion of the sale, the senior vice president owned 15,722 shares of the company’s stock, valued at approximately $1,159,025.84. This trade represents a 14.70% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 17,801 shares of company stock worth $1,347,481. 0.88% of the stock is currently owned by insiders.

Ingevity Profile

(Free Report)

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.